Q1: 2026-04-30 Earnings Summary

EPS of $0.36 beats by $0.05

|

Revenue of

$2.70B

(2.90% Y/Y)

beats by $85.52M

Baxter International Inc. ( BAX ) Q1 2026 Earnings Call April 30, 2026 8:30 AM EDT

Company Participants

Kevin Moran - Vice President & Head of Investor Relations

Andrew Hider - CEO, President, Interim Group President of Medical Products & Therapies and Director

Anita Zielinski - Interim CFO, Senior VP, Chief Accounting Officer & Controller

Conference Call Participants

Robert Marcus - JPMorgan Chase & Co, Research Division

David Roman - Goldman Sachs Group, Inc., Research Division

Larry Biegelsen - Wells Fargo Securities, LLC, Research Division

Vijay Kumar - Evercore ISI Institutional Equities, Research Division

Matthew Miksic - Barclays Bank PLC, Research Division

Matthew Taylor - Jefferies LLC, Research Division

Joanne Wuensch - Citigroup Inc., Research Division

Jayson Bedford - Raymond James & Associates, Inc., Research Division

Presentation

Operator

Good morning, ladies and…